138 related articles for article (PubMed ID: 10502441)
1. Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
Umesaki N; Izumi R; Fushiki H; Hasegawa K; Kono I; Nishida M; Noguchi H; Okuda H; Sugimori H; Takizawa K; Udagawa Y; Yamamoto K; Tanaka T; Noda K
Gynecol Oncol; 1999 Oct; 75(1):142-4. PubMed ID: 10502441
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
Iwasaka T; Fukuda K; Hara K; Yokoyama M; Nakao Y; Uchiyama M; Sugimori H
Gynecol Oncol; 1998 Aug; 70(2):236-40. PubMed ID: 9740697
[TBL] [Abstract][Full Text] [Related]
3. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.
Wheelock JB; Krebs HB; Goplerud DR; Myers M
Obstet Gynecol; 1985 Sep; 66(3):410-2. PubMed ID: 4040622
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study.
Pierga JY; Dieras V; Paraiso D; Dorval T; Palangie T; Beuzeboc P; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
Gynecol Oncol; 1996 Jan; 60(1):59-63. PubMed ID: 8557229
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT
Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
Pierga JY; Diéras V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
Gynecol Oncol; 1997 Aug; 66(2):246-9. PubMed ID: 9264570
[TBL] [Abstract][Full Text] [Related]
7. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
Moore KN; Herzog TJ; Lewin S; Giuntoli RL; Armstrong DK; Rocconi RP; Spannuth WA; Gold MA
Gynecol Oncol; 2007 May; 105(2):299-303. PubMed ID: 17303230
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
Shimizu Y
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():359-77. PubMed ID: 10895181
[TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
[TBL] [Abstract][Full Text] [Related]
11. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
Mabuchi S; Morishige K; Fujita M; Tsutsui T; Sakata M; Enomoto T; Kimura T
Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin/etoposide chemotherapy for recurrent or primarily advanced cervical carcinoma.
Al-Saleh E; Hoskins PJ; Pike JA; Swenerton KD
Gynecol Oncol; 1997 Mar; 64(3):468-72. PubMed ID: 9062152
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
Chauvergne J; Héron JF; Mayer F; Charrot-Chinet P; Toulouse C
Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
[TBL] [Abstract][Full Text] [Related]
14. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
Kastritis E; Bamias A; Efstathiou E; Gika D; Bozas G; Zorzou P; Sarris K; Papadimitriou C; Dimopoulos MA
Gynecol Oncol; 2005 Nov; 99(2):376-82. PubMed ID: 16051322
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
Aoki Y; Sato T; Watanabe M; Sasaki M; Tsuneki I; Tanaka K
Gynecol Oncol; 2001 Jun; 81(3):496-9. PubMed ID: 11371145
[TBL] [Abstract][Full Text] [Related]
16. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
17. Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.
Senapad S; Neungton S; Usavajindawath C; Vijatrasil S; Thaithanaisawanya V
J Med Assoc Thai; 1989 Jul; 72(7):382-6. PubMed ID: 2507723
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
[TBL] [Abstract][Full Text] [Related]
19. [A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer].
Ikeda K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Usui N; Nakada H; Adachi K; Yamazaki H; Tada A
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):536-40. PubMed ID: 4004284
[TBL] [Abstract][Full Text] [Related]
20. [The immediate results of the combined chemotherapy of disseminated forms and recurrences of cervix uteri cancer with vincristine, platidiam and adriamycin].
Zabunov AV; Dudareva LA
Vopr Onkol; 1991; 37(11-12):1090-4. PubMed ID: 1669203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
